Search Results - Sanchez-Kobashi, R

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

    PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma by Alva, M, Gay, J.G, Sanchez Kobashi, R

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in Mexico

    PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in Mexico by Lechuga, D, Alva, M, Sanchez-Kobashi, R, Gay, J.G

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions

    PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions by Lechuga, D, Alva, M, Gay, J.G, Sánchez-Kobashi, R

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery

    Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery by Vargas-Romero, J.A, Figueroa-Rodriguez, A, Chiu-Ugalde, J, Sánchez-Kobashi, R, Gay-Molina, J.G, López-Alvarenga, J.C

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting

    PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting by Gay-Molina, J.G, Sánchez-Kobashi, R, Muciño-Ortega, E, Gutiérrez-Colín, C.I, Galindo-Suárez, R.M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    PGI22 Cost-Effectiveness Analysis of Dexlansoprazole for the Treatment of Erosive Esophagitis Compared to Conventional Proton Pump Inhibitors

    PGI22 Cost-Effectiveness Analysis of Dexlansoprazole for the Treatment of Erosive Esophagitis Compared to Conventional Proton Pump Inhibitors by Valencia-Romero, A, Gay-Molina, J.G, Chiu-Ugalde, J, Figueroa-Rodriguez, A, López-Alvarenga, J.C, Sánchez-Kobashi, R, Vargas, J.A

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PCV66 Pharmacoeconomic Analysis of Azilsartan Medoxomil in Patients With Arterial Hypertension: Comparison With Valsartan, Telmisartan, Losartan and Irbesartan in the Mexican Context

    PCV66 Pharmacoeconomic Analysis of Azilsartan Medoxomil in Patients With Arterial Hypertension: Comparison With Valsartan, Telmisartan, Losartan and Irbesartan in the Mexican Conte... by Zamora Muciño-Arroyo, A.J, Gay-Molina, J.G, Chiu-Ugalde, J, Figueroa-Rodriguez, A, Arellano Plancarte, A, López-Alvarenga, J.C, Sánchez-Kobashi, R, Vargas, J.A

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    PCN21 - Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery

    PCN21 - Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery by Vargas-Romero, J.A., Figueroa-Rodriguez, A., Chiu-Ugalde, J., Sánchez-Kobashi, R., Gay-Molina, J.G., López-Alvarenga, J.C.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: